{name}
{subtitle}
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~25 mi. (Nottingham, United Kingdom, +199 more cities)
facility
Nottingham University Hospitals NHS Trust ( Site 0756)
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)
city
~25 mi. (Nottingham, United Kingdom, +127 more cities)
facility
Nottingham City Hospital ( Site 2907)
drug
lenvatinib, +1 more drug
drug type
immunotherapy, +1 more type
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
city
~25 mi. (Nottingham, United Kingdom, +126 more cities)
facility
Nottingham University Hospitals NHS Trust ( Site 0476)
drug
FOLFOX regimen, +3 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
city
~25 mi. (Nottingham, United Kingdom, +92 more cities)
facility
Nottingham University Hospital NHS Trust ( Site 0250)
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~25 mi. (Nottingham, United Kingdom, +156 more cities)
facility
Nottingham University Hospitals NHS Trust /ID# 223292
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type
Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)
city
~25 mi. (Nottingham, United Kingdom, +98 more cities)
facility
Nottingham University Hospital
condition
Follicular Lymphoma, +1 more condition
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
city
~32 mi. (Sheffield, United Kingdom, +108 more cities)
facility
Weston Park Hospital
drug
carboplatin, +5 more drugs
drug type
chemotherapy, +1 more type
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~32 mi. (Sheffield, United Kingdom, +145 more cities)
facility
Weston Park Hospital ( Site 1801)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types